In Vitro Antimicrobial Activity of Natural Products Using Minimum Inhibitory Concentrations: Looking for New Chemical Entities or Predicting Clinical Response

In previous comments, the difficulties and technical problems of selectivity criteria was exposed related to the antimicrobial activity of extracts plants and pure compounds based in MICs, opening an interesting discussion about this topic. In this way, this commentary seeks to give more elements that feed the proposed debate.

[1]  G. Filoche Biodiversity Fetishism and Biotechnology Promises in Brazil: From Policy Contradictions to Legal Adjustments , 2012 .

[2]  C. Roersch Commentary: A classification system for antimicrobial activity based on MIC-values: fake or reality? , 2012, Journal of ethnopharmacology.

[3]  V. Kouznetsov,et al.  Antimycobacterial susceptibility testing methods for natural products research , 2010, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].

[4]  A. Omar,et al.  Differences in Cell Wall Thickness between Resistant and Nonresistant Strains of Mycobacterium tuberculosis: Using Transmission Electron Microscopy , 2009, Chemotherapy.

[5]  Alain R. Baulard,et al.  Organization of the mycobacterial cell wall: a nanoscale view , 2008, Pflügers Archiv - European Journal of Physiology.

[6]  S. Gibbons Phytochemicals for Bacterial Resistance - Strengths, Weaknesses and Opportunities , 2007, Planta medica.

[7]  Cori Bargmann,et al.  Detection and avoidance of a natural product from the pathogenic bacterium Serratia marcescens by Caenorhabditis elegans , 2007, Proceedings of the National Academy of Sciences.

[8]  L. Maes,et al.  Anti-infective potential of natural products: how to develop a stronger in vitro 'proof-of-concept'. , 2006, Journal of ethnopharmacology.

[9]  Frederick M Ausubel,et al.  Identification of novel antimicrobials using a live-animal infection model , 2006, Proceedings of the National Academy of Sciences.

[10]  M. Motyl,et al.  Basic Microbiological Techniques Used in Antibacterial Drug Discovery , 2005, Current protocols in pharmacology.

[11]  D. Bojanic Handbook of Drug Screening. , 2001, Drug discovery today.

[12]  L. Reimer,et al.  Antibiotics in laboratory medicine , 1987 .

[13]  Brad Spellberg,et al.  The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  R. Seethala,et al.  Comprar Handbook of Drug Screening, Second Edition | Ramakrishna Seethala | 9781420061697 | Informa Healthcare , 2008 .